{"nct_id":"NCT04640623","title":"A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2020-12-18","start_date_type":"ACTUAL","primary_completion_date":"2026-11-20","primary_completion_date_type":"ESTIMATED","completion_date":"2027-07-02","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JNJ"]}